anticoagulating disorders Flashcards
(16 cards)
hemophilia
most common hereditary disease
hemophilia A and B
both sex-linked recessive
associated w/ HIV and hep c
risk of intracranial hemorrhage worsens prognosis
hemophilia A
deficient in fact 8
easy bruising
massive bleeding with trauma and surgery
hemarthroses (bleeding into joints)
no petechiae
normal bleeding time, platelet count, PT
increased PTT
factor 8 assay
factor 8 replacement
hemophilia B
factor 9 deficiency
less common
x-linked recessive
no petechiae
normal bleeding time, platelet count, PT
increased PTT
factor 9 assay
factor 9 replacement
von willebrand disease
most common bleeding disorder
autosomal dominant
type 1 most common
easy bruising
mucosal surface bleeding (GI)
menorrhagia
NSAIDS and ASA worsen symps
increased bleeding time
decreased factor 8 acitivity
give high-purity factor 8 containing von willebrand factor
PLT transfusions
DDAVP (desmopressin)
deficiencies of vitamin K dependent factors
affects clotting factors 2, 7, 9, and 10
autosomally inherited
prolonged bleeding of umbilical cord stump
factor 7 deficiency= increased PT/INR and normal aPPT
factor 2 or 10 deficiency= increased PT/INR and aPPT
transfusion
causes of vit. K deficiency
eradication of gut flora (antibiotics)
nutritional deficiency (critical illness or TPN)
malabsorption of fat soluble vitamins or small bowel (celiac sprue or IBD)
diagnosis and treatment of vitamin K deficiency
PT and INR
oral vit. K
parenteral vit. K
transfusion
liver failure and bleeding
impairs activation of vitamin K dependent clotting factors (2, 7, 9, 10)
portal hypertension causes pooling of platelets in spleen leading to thrombocytopenia-> can lead to GI bleed
bleeding w/ renal insufficiency
purpura, epistaxis, GI bleeding
normal PLT
hemodialysis
DIC
disseminated intravasuclar coagulation
caused via malignancy, infection, pregnancy
thrombin, fibrin, and platelets become activated
rapid thrombosis consumes factors faster than they can be replaced
hemostasis->coagulation->hemorrhage
DIC labs
increased PT/INR
increased aPPT
thrombocytopenia
increased fibrin degradation products
schistocytes
treatment of DIC
platelet and FFP transfusion
cryroprecipitate
PRBCs
antifibrinolytic agents are contraindicated
hypercoaguable states
thrombophilias
increased risk of thrombosis
genetic
deficiency of anti-thrombic factor (antithrombin 3)
increase in prothrombic factor (hyperhomocysteinemia)->atherosclerosis and VTE
treated via TPA (dissolves blood clots)
plavix/asprin
refer to hematologist
coumadin/xarelto/lovenox (pregnancy)
general treatment of bleeding
FFP
cryoprecipitate
vit. K
vit. K and FFP
reverse coumadin
protamine sulfate
reverses heparin